Woodline Partners’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-131,200
Closed -$1.36M 580
2023
Q3
$1.36M Sell
131,200
-60,973
-32% -$706K 0.02% 426
2023
Q2
$2.52M Sell
192,173
-577,913
-75% -$7.07M 0.03% 400
2023
Q1
$8.61M Buy
770,086
+4,288
+0.6% +$42.3K 0.12% 216
2022
Q4
$6.46M Buy
765,798
+217,286
+40% +$2.07M 0.09% 275
2022
Q3
$9.14M Buy
548,512
+116,880
+27% +$2.15M 0.13% 210
2022
Q2
$6.35M Sell
431,632
-25,023
-5% -$515K 0.1% 226
2022
Q1
$11.3M Buy
456,655
+95,048
+26% +$2.45M 0.18% 161
2021
Q4
$11.6M Buy
361,607
+25,294
+8% +$924K 0.17% 171
2021
Q3
$12.1M Buy
336,313
+40
+0% +$1.57K 0.2% 143
2021
Q2
$14.8M Buy
336,273
+208,181
+163% +$9.07M 0.28% 97
2021
Q1
$5.86M Buy
128,092
+116
+0.1% +$6.65K 0.13% 178
2020
Q4
$8.83M Buy
+127,976
New +$6.27M 0.23% 122

Other funds holding LUNG

Woodline Partners's LUNG Position: Q4 2023 in Review

Woodline Partners sold out of Pulmonx (LUNG) in Q4 2023, closing a stake of 131,200 shares — an estimated $1.36M sold.

Woodline Partners first reported a position in LUNG in Q4 2020 and held it in 12 quarters. The position peaked at $14.8M in Q2 2021. 123 funds tracked by Wall St. Rank hold LUNG as of Q4 2023.

  • Woodline Partners reported no remaining Pulmonx position as of Q4 2023 after selling out during the quarter.
  • Woodline Partners sold 131,200 Pulmonx shares in Q4 2023, an estimated $1.36M.
  • Woodline Partners first reported a position in Pulmonx in Q4 2020 and held it in 12 quarters.
  • Woodline Partners's Pulmonx position peaked at $14.8M in Q2 2021.
  • 123 funds tracked by Wall St. Rank held Pulmonx as of Q4 2023.

Based on Woodline Partners's 13F filing for Q4 2023, filed 14 Feb 2024.